Zhejiang Hugeleaf Co.,Ltd.

Shanghai Stock Exchange 600226.SS

Zhejiang Hugeleaf Co.,Ltd. Price to Sales Ratio (P/S) on January 14, 2025: 12.07

Zhejiang Hugeleaf Co.,Ltd. Price to Sales Ratio (P/S) is 12.07 on January 14, 2025, a 1.26% change year over year. Price to sales ratio compares the stock price to the sales per share; higher suggests positive sentiment for future revenue growth.

Zhejiang Hugeleaf Co.,Ltd. 52-week high Price to Sales Ratio (P/S) is 12.74 on December 11, 2024, which is 5.61% above the current Price to Sales Ratio (P/S).
Zhejiang Hugeleaf Co.,Ltd. 52-week low Price to Sales Ratio (P/S) is 8.65 on September 23, 2024, which is -28.32% below the current Price to Sales Ratio (P/S).
Zhejiang Hugeleaf Co.,Ltd. average Price to Sales Ratio (P/S) for the last 52 weeks is 10.69.

Key data

Date	Price to Sales Ratio (P/S)	Price to Book Ratio (P/B)	Dividend Yield	Free Cash Flow Yield

Shanghai Stock Exchange: 600226.SS

Zhejiang Hugeleaf Co.,Ltd.

CEO	Mr. Wei Cui
IPO Date	Nov. 16, 1999
Location	China
Headquarters	Global Metropolis Plaza
Employees	815
Sector	Health Care
Industries Biotechnology Agriculture Pharmaceuticals

Description

Zhejiang Hugeleaf Co.,Ltd. produces and sells biological pesticides, veterinary drugs, and feed additive products. It also engages in the combined heat and power, online game research and development, and agency distribution and other related businesses. The company was formerly known as Zhejiang Shenghua Biok Biology Co., Ltd. and changed its name to Zhejiang Huge Leaf Co., Ltd. in May 2017. Zhejiang Huge Leaf Co., Ltd. is based in Shanghai, China.

Key trends

Past 5 years